Want to see IN:ERIS full AI Analyst Report?
Eris Lifesciences Ltd (ERIS) Income Statement
Eris Lifesciences Ltd Income Statement
Last quarter (Q4 2026), Eris Lifesciences Ltd's total revenue was $7.67B, an increase of 9.14% from the same quarter last year. In Q4, Eris Lifesciences Ltd's net income was $2.82B. See Eris Lifesciences Ltd’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| $ 31.29B | $ 28.79B | $ 19.91B | $ 16.62B | $ 13.26B | |
| $ 14.98B | $ 21.49B | $ 16.04B | $ 13.05B | $ 10.65B | |
| $ 6.57B | $ 14.46B | $ 11.08B | $ 8.83B | $ 6.40B | |
| Depreciation and Amortization | $ 2.79B | $ 3.15B | $ 1.83B | $ 1.17B | $ 647.05M |
| $ 11.11B | $ 10.36B | $ 6.99B | $ 5.48B | $ 5.11B | |
| $ 8.41B | $ 7.03B | $ 4.95B | $ 4.22B | $ 4.25B | |
| $ -2.02B | $ -2.14B | $ -640.70M | $ -175.48M | $ 171.36M | |
| $ 6.39B | $ 4.89B | $ 4.31B | $ 4.05B | $ 4.42B | |
| $ 6.20B | $ 3.52B | $ 3.92B | $ 3.82B | $ 4.06B | |
| Per Share Metrics | |||||
| Basic EPS | $ 45.33 | $ 25.85 | $ 28.82 | $ 28.10 | $ 29.89 |
| Diluted EPS | $ 45.33 | $ 25.81 | $ 28.79 | $ 28.07 | $ 29.88 |
| Weighted Average Shares Outstanding | 136.67M | 136.32M | 136.01M | 135.98M | 135.87M |
| Weighted Average Shares Outstanding (Diluted) | 136.67M | 136.32M | 136.17M | 136.17M | 135.91M |
Currency in INR